Advertisement
Canada markets close in 2 hours 6 minutes

  • S&P/TSX

    22,317.87
    -57.96 (-0.26%)
     

  • S&P 500

    5,217.90
    +3.82 (+0.07%)
     

  • DOW

    39,484.33
    +96.57 (+0.25%)
     

  • CAD/USD

    0.7315
    +0.0003 (+0.05%)
     

  • CRUDE OIL

    78.30
    -0.96 (-1.21%)
     

  • Bitcoin CAD

    82,458.55
    -2,487.63 (-2.93%)
     

  • CMC Crypto 200

    1,252.35
    -105.66 (-7.50%)
     

  • GOLD FUTURES

    2,375.60
    +35.30 (+1.51%)
     

  • RUSSELL 2000

    2,056.03
    -17.60 (-0.85%)
     

  • 10-Yr Bond

    4.4980
    +0.0490 (+1.10%)
     

  • NASDAQ

    16,322.99
    -23.28 (-0.14%)
     

  • VOLATILITY

    12.71
    +0.02 (+0.16%)
     

  • FTSE

    8,433.76
    +52.41 (+0.63%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • CAD/EUR

    0.6786
    +0.0008 (+0.12%)
     
MARKETS LIVE BLOG:

STOCKS RISE AS DOW EYES GAIN FOR 8TH STRAIGHT SESSION

U.S. consumer sentiment tumbles in May as inflation, interest rate worries take hold

EU regulator conditionally approves Abbott's purchase of St Jude

Reuters
The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., April 28, 2016. REUTERS/Brendan McDermid/File Photo

BRUSSELS (Reuters) - The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories' (NYSE:ABT - News) bid for peer St Jude Medical Inc (NYSE:STJ - News).

Reuters reported on Nov. 15 that the $25 billion deal was going to be cleared in Brussels.

The European Commission, the mergers regulator, said in a statement that its approval was conditional on "Abbott divesting two devices used in cardiovascular treatments."

(Reporting by Gabriela Baczynska)